COMMUNIQUÉS West-GlobeNewswire

Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Subsidiary of AbbVie, to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders
12/11/2025
PARMA, Italy, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Chiesi Group today announced it has entered into an exclusive license agreement with Aliada Therapeutics, a wholly owned subsidiary of AbbVie, to advance blood-brain [...]
Radiopharm Theranostics starts enrollment of the Third Cohort of Phase 1 Dose Escalation Clinical Trial of 177Lu-RAD204
12/11/2025
Data Safety Monitoring Committee approves advancing to a higher dose of 90mCi The first two Cohorts’ patients show tumor uptake and a favourable safety profile SYDNEY, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Radiopharm [...]
Jushi Holdings Inc. Announces Grand Opening of Beyond Hello™ Little Ferry in New Jersey
12/11/2025
Company’s first dispensary in the Garden State and 8 th state where the Company operates Opened to the public on November 7, 2025 Grand opening celebration with exclusive promotions expected November 21, 2025 A Media [...]
Aprea Therapeutics Reports Third quarter 2025 Financial Results and Provides a Clinical Update
12/11/2025
APR-1051 (WEE1 kinase inhibitor): In ongoing Phase 1 ACESOT-1051dose-escalation trial, 3 out of 4 patients at Dose Level 6 (100 mg once daily) achieved stable disease, per RECIST v1.1, in heavily pretreated [...]
Solana Company Announces Intent to Tokenize HSDT Shares on Superstate’s Opening Bell
12/11/2025
NEWTOWN, Pa., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company that has expanded its business to include a digital asset treasury dedicated to [...]
Indaptus Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
12/11/2025
NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection [...]
Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand
12/11/2025
TORONTO, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, [...]
IO Biotech Announces Participation in Upcoming Investor Conferences
12/11/2025
NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that [...]
Chiesi Group Enters into an Exclusive License Agreement with Aliada Therapeutics, a Wholly Owned Subsidiary of AbbVie, to Advance Blood-Brain Barrier-Crossing Platform Technology in Lysosomal Storage Disorders
12/11/2025
PARMA, Italy, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Chiesi Group today announced it has entered into an exclusive license agreement with Aliada Therapeutics, a wholly owned subsidiary of AbbVie, to advance blood-brain [...]
Intelligent Bio Solutions Reports Fiscal 2026 First Quarter Financial Results and Operational Highlights, Delivering Record Revenue Growth
12/11/2025
Record quarterly revenue of $1.11 million, an increase of 32% sequentially and 28% year-over-year, driven by consumable cartridge sales and customer base expansion Gross profit margins increased 690 basis points year- [...]
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025
12/11/2025
WILMINGTON, Del., Nov. 12, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it will release its [...]
Moleculin Announces Grant Funded Research Evaluating Annamycin for the Treatment of Pancreatic Cancer at UNC-Chapel Hill
12/11/2025
Preclinical research to be conducted at the University of North Carolina at Chapel Hill (UNC) Annamycin will be used in conjunction with novel agents and modalities Preclinical studies indicate Annamycin targets key [...]
Easy Environmental Solutions, Inc. Announces Second EasyFEN Deployment Agreement as Rollout Accelerates Across Africa
12/11/2025
New deployment has the potential to generate up to $24 million in annual recurring revenue at full production MANKATO, Minn., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Easy Environmental Solutions, Inc. (OTC: EZES) today [...]
Earth Science Tech, Inc. Reports Strong Q2 Fiscal 2025 Results
12/11/2025
MIAMI, FL, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential operating businesses, today [...]
Immix Biopharma Appoints Chief Commercial Officer to Drive NXC-201 Launch
12/11/2025
- Former Chimerix (CMRX, acquired by Jazz for $935 million) Senior Commercial Leader Michael Grabow led Go-To-Market Strategy and Launch for rare disease therapeutic MODEYSO® - - Rare disease commercial veteran Mr. [...]
Marius Pharmaceuticals Expands Global Footprint with Health Canada Approval of KYZATREX® (testosterone undecanoate) CIII Capsules
12/11/2025
RALEIGH, N.C., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, Inc. a patient-centric healthcare company committed to advancing innovative therapies for testosterone deficiency, today announced that Health [...]
Mochi Health Expands Beyond Obesity Care with Comprehensive Digital Health Platform, Adding 15 New Categories of Care
12/11/2025
Physician-guided telehealth company deepens access to personalized, evidence-based treatments across dermatology, women’s health, sexual wellness, and beyond SAN FRANCISCO, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Mochi Health [...]
Connect Biopharma Reports Third Quarter 2025 Financial Results and Provides Business Update
12/11/2025
– Recruitment ongoing for Phase 2 Seabreeze STAT studies for acute exacerbations in asthma and COPD; expect to report topline data from both studies in 1H26 – – New Drug Application for rademikibart for the treatment of [...]
Aeroflow Health and AlohaCare Partner to Expand Access to DME in Hawaii
12/11/2025
AlohaCare members now have streamlined access to durable medical equipment offered by Aeroflow, helping them manage maternal health, sleep, incontinence and diabetes care from home ASHEVILLE, N.C., Nov. 12, 2025 (GLOBE [...]

Pages